8
Tetrahedron
ACCEPTED MANUSCRIPT
o
1
J = 16 Hz, 1 H, piperidine-H), 3.91-3.96 (m, 2H, NCH CH),
4a: Yield: 57.7 mg, 45%; m.p = 190-192 C. H NMR
(CDCl , δ, ppm): 7.00, 6.87 (s, 2 H, NC H (CH ) ), 5.41-5.50
2
3
.35-3.48 (m, 2 H, piperidine-H), 2.31, 2.47, 2.50 (s, 9 H,
3
6
2
3 3
13
NC H (CH ) ), 1.18-2.00 (m, 6 H, piperidine-H). C NMR
(m, 1 H, piperidine-H), 4.79-4.93 (m, 2 H, piperidine-H), 3.73-
6
2
3 3
(
CDCl , δ, ppm): 179.1 (NCN), 152.6, 138.5, 137.7 (Py-C), 3.83 (m, 2 H, NCH CH, COD-CH), 3.56-3.61 (m, 1 H, COD-
3
2
1
4
34.6, 129.8, 129.7, 124.4 (Ar-C), 59.9 (NHCH CH), 57.6,
CH), 3.18-3.28 (m, 2 H, NCH CH, COD-CH), 3.11-3.16 (m, 1
2
2
9.1, 32.8, 25.9, 23.7 (piperidine-C), 21.3, 20.2 (NC H (CH ) ).
H, COD-CH), 2.52, 2.05 (d, J = 4.0 Hz, 6 H, NC H (CH ) ),
6
2
3 3
6
2
3 3
Anal. Calc. for C H Br N Pd: C, 42.92; H, 4.63; N, 7.15.
2.34-2.39 (m, 2 H, piperidine-H), 2.32 (s, 3 H, NC H (CH ) ),
2
1
27
2
3
6 2 3 3
Found: C, 42.88; H, 4.52; N, 7.30.
1.81-1.95 (m, 8 H, piperidine-H, COD-CH ), 1.39-1.65 (m, 8
2
13
o
1
H, piperidine-H, COD-CH
2
). C NMR (CDCl
, δ, ppm): 208.3
3
3
b: Yield: 50%; m.p = 328-330 C. H NMR (CDCl , δ,
1
3
(
d, J
= 57.7, Rh-Ccarbene), 138.2, 138.1, 137.6, 137.5, 136.1,
Rh-C
ppm): 8.73-8.75 (m, 2 H, Py-H), 7.59-7.64 (m, 1 H, Py-H), 7.39
t, J = 8.0 Hz, 2 H, Py-H), 7.30 (d, J = 12.5 Hz, 2 H,
NC H [CH(CH ) ] ), 7.16-7.19 (m, 1 H, NC H [CH(CH ) ] ),
1
35.1 (Ar-C), 97.2 (d, J = 9.2 Hz, COD-CH), 69.4 (d, J = 14.0
(
Hz, COD-CH), 59.6 (NCH CH), 57.4, 49.5, 34.3, 32.9, 30.8,
2
6
3
3 2 2
6
3
3 2 2
3
0.6, 29.7, 27.6, 27.1, 23.7 (piperidine-C, COD-CH ), 21.0 20.4
2
5
.47 (dd, J = 4.4, 12.8 Hz, 1 H, piperidine-H), 3.43-4.04 (m, 6
(
NC H (CH ) ). Anal.Calc. for C H BrN Rh: C, 54.05; H,
6 2 3 3 24 34 2
H, NCH CH, piperidine-H, NC H [CH(CH ) ] ), 1.59-2.09 (m,
2
6
3
3 2 2
6
.43; N, 5.25. Found: C, 54.12; H, 6.51; N, 5.34.
6
H, piperidine-H), 1.46, 1.16 (t, J = 12.0 Hz, 12 H,
13
o
1
NC H [CH(CH ) ] ). C NMR (CDCl , δ, ppm): 179.6 (NCN),
4b: Yield: 75.2 mg, 45%; m.p= 201-203 C. H NMR
(CDCl , δ, ppm): 7.29-7.34 (m, 2 H, NC H [CH(CH ) ] ), 7.11-
6
3
3 2 2
3
1
6
2
52.3, 148.3, 137.4 (PyC), 134.2, 129.4, 124.5, 124.2 (Ar-C),
0.1 (NCH CH), 59.5 (NC H [CH(CH ) ] ), 49.3, 32.3, 28.3,
3
6
3
3 2 2
7.14 (m, 2 H, NC H [CH(CH ) ] ), 5.43-5.54 (m, 1 H,
2
6
3
3 2 2
6
3
3 2 2
6.9,
26.8
(piperidine-C),
25.6,
24.4,
23.4
piperidine-H), 4.83-4.94 (m, 2 H, piperidine-H), 3.71-3.88 (m,
(
NC H [CH(CH ) ] ). Anal. Calc. for C H Br N Pd: C, 45.77; 3 H, NCH CH, COD-CH), 3.55-3.60 (m, 1 H, COD-CH), 3.33-
6
3
3 2 2
24 33
2
3
2
H, 5.28; N, 6.67. Found: C, 45.79; H, 5.53; N, 6.84.
3.45, 2.88-2.97 (m, 2 H, COD-CH), 2.69-2.80, 2.27-2.39 (m, 2
o
1
H, NC H [CH(CH ) ] ), 1.72-2.14, 1.62-1.55, 1.31-1.38 (m, 10
6 3 3 2 2
3
c: Yield: 80%; m.p= 272-274 C. H NMR (CDCl , δ,
3
H, piperidine-H, COD-CH ), 1.09, 1.20, 1.49 (m, 12 H,
2
ppm): 9.02-9.04 (m, 2H, Py-H), 7.12-7.76 (m, 1 H, Py-H),
.29-7.33 (m, 2 H, Py-H), 6.87 (s, 2 H, NCH C H (CH ) ), 5.25
s, 2 H, NCH C H (CH ) ), 5.08-5.12 (dd, J = 4.4, 13.2 Hz, 1
H, piperidine-H), 3.66-3.71 (m, 1 H, NCH CH), 3.26-3.35 (m,
H, NCH CH, piperidine-H), 2.73-2.77 (m, 1 H, piperidine-H),
13
NC H [CH(CH ) ] ). C NMR (CDC , δ, ppm): 208.9 (dd, J
6
3
3 2 2
l3
Rh-
7
(
2
6
2
3 3
=
46.0, Rh-Ccarbene), 149.3, 146.1, 135.9, 128.7, 124.9, 123.5
Ar-C), 97.6 (d, J = 6.0 Hz, COD-CH), 68.2 (dd, J = 14.0 Hz,
COD-CH), 60.4, 60.1, 59.5, 59.1, 50.0, 48.6, 34.6, 32.6, 30.3,
C
2 6 2 3 3
(
2
2
2
2
2
9.7, 28.1, 27.2, 26.6, 25.2, 23.1 ( NC H [CH(CH ) ] ).
6 3 3 2 2
.27, 2.41 (s, 9 H, NCH C H (CH ) ), 1.36-1.96 (m, 6 H,
2
6
2
3 3
1
3
Anal.Calc. for C27H40BrN Rh: C, 56.36; H, 7.01; N, 4.87.
2
piperidine-H). C NMR (CDCl , δ, ppm): 178.4 (NCN), 152.4,
38.4, 137.8 (PyC), 137.7, 129.2, 128.3, 124.5 (Ar-C), 59.2
NCH CH), 53.8 (NCH C H (CH ) ), 48.6, 48.3, 31.9, 25.5,
3.2 (piperidine-C), 20.8, 20.9 (NCH C H (CH ) ). Anal. Calc.
2 6 2 3 3
3
Found: C, 56.41; H, 7.19; N, 5.02.
1
(
2
o
1
4c: Yield: 447.2 mg, 68%; m.p= 168-170 C. H NMR
(CDCl , δ, ppm): 6.85 (s, 2 H, NCH C H (CH ) ), 5.25-5.48
2
2
6
2
3 3
3
2
6
2
3 3
for C H Br N Pd: C, 43.91; H, 4.86; N, 6.98. Found: C,
(m, 1 H, NCH C H (CH ) ), 4.87-5.12 (m, 3 H, COD-CH,
2
2
29
2
3
2 6 2 3 3
4
4.01; H, 4.81; N, 7.11.
NCH C H (CH ) , 3.45-3.56 (m, 4 H, COD-CH, piperidine-H),
2 6 2 3 3
o
1
3.09-3.21 (m, 2H, NCH
2
CH), 2.57-2.64 (m, 2 H, piperidine-H),
3
d: Yield: 68%; m.p = 322-324 C. H NMR (CDCl , δ,
3
2
.36, 2.26 (s, 9 H, NCH C H (CH ) ), 2.25-2.49 (m, 4 H,
2
6
2
3 3
ppm): 9.04 (dd, J = 5.6 Hz, 2 H, Py-H), 7.35 (t, J = 7.6 Hz, 1 H,
Py-H), 7.32 (t, J = 5.6 Hz, 2 H, Py-H), 7.03 (s, 2 H,
13
piperidine-H), 1.86-1.97, 1.29-1.50 (m, 8 H, COD-CH2).
C
NMR (CDC , δ, ppm): 208.9 (dd, J
= 46.0, Rh-Ccarbene),
l3
Rh-C
NCH C H [CH(CH ) ] ),
5.27-5.35
(m,
2
H,
2
6
2
3 2 3
1
9
38..2, 137.5, 129.2, 129.1 (CH C H (CH ), 98.5, 98.4, 98.1,
8.0 (COD-CH), 70.1, 69.5, 67.8, 67.4 (COD-CH), 59.1
2 6 2 3
NCH C H [CH(CH ) ] ), 5.07-5.10 (m, 1 H, piperidine-H),
.28-3.68-9 (m, 5 H, NCH CH, NCH C H [CH(CH ) ] ), 2.79-
2 2 6 2 3 2 3
.90 (m, 2 H, piperidine-H), 1.37-1.95 (m, 6 H, piperidin-H),
.23-1.27 (m, 18 H, NCH C H [CH(CH ) ] ). C NMR
CDCl , δ, ppm): 178.2 (NCN), 152.5, 149.1, 148.9 (PyC),
37.7, 125.5, 124.4, 121.3 (Ar-C), 59.3 (NCH CH), 53.9
2
NCH C H [CH(CH ) ] ), 48.4, 46.5,
2
6
2
3 2 3
3
2
1
(
1
(
NCH CH), 54.1 (NCH C H (CH ) ), 48.3, 33.1, 32.2, 31.9,
2 2 6 2 3 3
1
3
31.7, 29.5, 28.4, 26.6, 26.1 (piperidine-C, CODCH
), 22.6
2
2
6
2
3 2 3
(
C H (CH ) -o-CH ), 20.7 (C H (CH ) -p-CH ). Anal. Calc. for
6
2
3 3
3
6
2
3 3
3
3
C H BrN Rh: C, 54.86; H, 6.63; N, 5.12. Found: C, 54.93; H,
2
5
36
2
6
.59; N, 5.25.
(
(
34.2, 31.6, 29.2
2
6
2
3 2 3
o
1
piperidine-C),
25.5,
24.4,
24.3, 23.9, 23.2
4c´: Yield: 423.4 mg, 70 %; m.p = 160-162 C. H NMR
(
NCH C H [CH(CH ) ] ). Anal. Calc. for C H Br N Pd: C,
(CDCl , δ, ppm): 6.80 (s, 2 H, NCH C H (CH ) ), 5.29-5.42
3 2 6 2 3 3
2
6
2
3 2 3
28 41
2
3
4
9.03; H, 6.03; N, 6.13. Found: C, 49.19; H, 6.12; N, 5.99.
(m, 1 H, NCH C H (CH ) ), 4.80-5.08 (m, 3 H, COD-CH,
2 6 2 3 3
NCH C H (CH ) , piperidine-H), 3.39-3.54 (m, 4 H, COD-CH,
2
6
2
3 3
4
.4. General procedure of [RhBr(NHC)COD] complexes
piperidine-H), 3.05-3.18 (m, 2H, NCH CH), 2.51-2.61 (m, 2 H,
2
piperidine-H), 2.32, 2.21 (s, 9 H, NCH C H (CH ) ), 2.24-2.42
[
Rh(µ-OMe)COD] (54.0 mg, 0.12 mmol) was added to 2a
2
6
2
3 3
2
(
m, 4 H, piperidine-H), 1.76-1.95, 1.47-1.21 (m, 8 H, COD-
(
100.0 mg, 0.24 mmol) and NaBr (46.0 mg, 0.48 mmol) which
was dissolved in dry toluene (6.0 ml) under argon atmosphere.
The reaction mixture was stirred 1 h at 25 C and then refluxed
for 48 h. Meanwhile the reaction progress was controlled with
layer chromatography. After removal of the solvent under
vacuum, the rhodium compound was purified by column
chromatography on silica gel using CH Cl to give a yellow
13
CH2). C NMR (CDCl , δ, ppm): 211.0 (dd, J = 45.0, Rh-
3
Rh-C
o
Ccarbene), 138.1, 137.4, 129.1, 128.9 (Ar-C), 98.2, 97.8 (d, J =
.0 Hz, COD-CH), 70.0, 67.5, (d, J = 14.0 Hz, COD-CH), 58.1
NCH C H (CH ) ), 54.1 (NCH CH), 48.0, 47.8, 33.2, 32.2,
6
(
2
6
2
3 3
2
3
2
5
2.1, 31.9, 29.4, 28.5, 26.1, 23.3, (piperidine-C, COD-CH2),
0.7 20.8 (NCH C H (CH ) ). Anal.Calc. for C H ClN Rh: C,
2
6
2
3 3
25 36
2
2
2
9.70; H, 7.21; N, 5.57. Found: C, 59.87; H, 7.75; N, 5.49.
solid. The residue was recrystallized from CH Cl / (C H ) O
2
2
2
5 2
(v/v = 3:10 mL)
4
.5. General procedure of [RhX(NHC)(CO) ] complexes
2